A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...
In patients with advanced or recurrent endometrial cancer (EC) with previous exposure to carboplatin and paclitaxel (PT), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback